Thomas H. Lee Advisors, Llc - May 14, 2021 Form 4/A - Amendment Insider Report for Syneos Health, Inc. (SYNH)

Role
Director
Signature
** See Exhibit 99.2 for Signatures
Stock symbol
SYNH
Transactions as of
May 14, 2021
Transactions value $
-$30,785,313
Form type
4/A - Amendment
Date filed
5/20/2021, 09:45 PM
Date Of Original Report
May 18, 2021
Previous filing
May 14, 2021
Next filing
Jun 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYNH Class A Common Stock Sale -$30.8M -380K -6.8% $81.04 5.21M May 12, 2021 See footnote F1, F2, F3, F4, F5, F6
transaction SYNH Class A Common Stock Sale -$5.19K -64 -6.99% $81.04 852 May 12, 2021 Direct F4, F7, F9
transaction SYNH Class A Common Stock Sale -$2.03K -25 -7.1% $81.04 327 May 12, 2021 Direct F4, F8, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 See Exhibit 99.1 for text of footnote (1).
F2 See Exhibit 99.1 for text of footnote (2).
F3 See Exhibit 99.1 for text of footnote (3).
F4 See Exhibit 99.1 for text of footnote (4).
F5 See Exhibit 99.1 for text of footnote (5).
F6 See Exhibit 99.1 for text of footnote (6).
F7 See Exhibit 99.1 for text of footnote (7).
F8 See Exhibit 99.1 for text of footnote (8).
F9 See Exhibit 99.1 for text of footnote (9).
F10 See Exhibit 99.1 for text of footnote (10).

Remarks:

Exhibit 99.1 (Form 4 Footnotes) and Exhibit 99.2 (Joint Filer Information) are incorporated herein by reference. This Form 4 is the first of two Forms 4 being filed relating to the same event. The Form 4 has been split into two filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 Reporting Persons. Each Form 4 will be filed by Designated Filer Thomas H. Lee Advisors, LLC. This amendment to Form 4 is being filed solely to (i) correct the number of shares reflected as being held by Fund VI 2019 following the closing of the Overallotment Option and the number of shares reflected as being distributed by Fund VI 2019 in footnote 6 to the Form 4 filed on March 18, 2021 (the "Original Form 4"), from 1,449,400 shares to 1,449,436 shares, and 12,806 shares to 12,770 shares, respectively, and (ii) correct the aggregate number of shares reflected as being held by the THL Funds as disclosed in Table I of the Original Form 4, from 5,208,835 shares to 5,208,871 shares.